Serologicals, Molecular Devices | GenomeWeb

Serologicals Acquires Upstate and Will Issue Shares to Molecular Devices

Serologicals will acquire Upstate Group for $205 million in stock and cash, according to SEC documents filed this week.

As part of the acquisition, Serologicals will issue shares to Molecular Devices and other Upstate shareholders, the company said in its 8-K filing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."